Home / Inspections / 1101234

FDA Inspection 1101234 — Minaris Regenerative Medicine, LLC

Minaris Regenerative Medicine, LLC — FEI 3003407523

The FDA completed an inspection of Minaris Regenerative Medicine, LLC on August 26, 2019 in Allendale, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 26, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Allendale, NJ (United States)

Facility

Other inspections at this facility

  • 1284408 (VAI Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1020396 (NAI Wed Apr 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 886646 (NAI Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources